Market closedNon-fractional
10x Genomics/TXG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About 10x Genomics
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Ticker
TXG
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Pleasanton, United States
Employees
1,259
Website
www.10xgenomics.com
10x Genomics Metrics
BasicAdvanced
$2.4B
Market cap
-
P/E ratio
-$2.24
EPS
1.89
Beta
-
Dividend rate
Price and volume
Market cap
$2.4B
Beta
1.89
Financial strength
Current ratio
5.215
Quick ratio
4.259
Long term debt to equity
11.275
Total debt to equity
12.823
Interest coverage (TTM)
-13,490.60%
Management effectiveness
Return on assets (TTM)
-13.06%
Return on equity (TTM)
-34.75%
Valuation
Price to revenue (TTM)
3.762
Price to book
3.31
Price to tangible book (TTM)
3.41
Price to free cash flow (TTM)
-31.815
Growth
Revenue change (TTM)
16.64%
Earnings per share change (TTM)
47.00%
3-year revenue growth (CAGR)
23.41%
3-year earnings per share growth (CAGR)
-24.13%
What the Analysts think about 10x Genomics
Analyst Ratings
Majority rating from 17 analysts.
10x Genomics Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$141M
-23.33%
Net income
-$60M
22.49%
Profit margin
-42.48%
59.76%
10x Genomics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.53
-$0.79
-$0.41
-$0.50
-
Expected
-$0.40
-$0.46
-$0.36
-$0.50
-$0.48
Surprise
31.31%
71.91%
14.40%
-0.08%
-
10x Genomics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for 10x Genomics stock?
10x Genomics (TXG) has a market cap of $2.4B as of July 26, 2024.
What is the P/E ratio for 10x Genomics stock?
The price to earnings (P/E) ratio for 10x Genomics (TXG) stock is 0 as of July 26, 2024.
Does 10x Genomics stock pay dividends?
No, 10x Genomics (TXG) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next 10x Genomics dividend payment date?
10x Genomics (TXG) stock does not pay dividends to its shareholders.
What is the beta indicator for 10x Genomics?
10x Genomics (TXG) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell 10x Genomics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.